Alternatives to animal testing

Mycrodose Therapeutics to Discuss Advanced Drug Delivery Devices at Psychedelic Medicine Event

Retrieved on: 
Tuesday, July 27, 2021

San Diego, California--(Newsfile Corp. - July 27, 2021) - Mycrodose Therapeutics, a US-Based pharmaceutical company focused on developing advanced drug delivery systems for use with psychedelic compounds, announced today that its Executive team will be participating in the upcoming Psychedelic Capital Event on July 29, 2021.

Key Points: 
  • San Diego, California--(Newsfile Corp. - July 27, 2021) - Mycrodose Therapeutics, a US-Based pharmaceutical company focused on developing advanced drug delivery systems for use with psychedelic compounds, announced today that its Executive team will be participating in the upcoming Psychedelic Capital Event on July 29, 2021.
  • The virtual conference hosted by Microdose Psychedelic Insights will enable Mycrodose Therapeutics the opportunity to present as a panel on the companys core drug delivery systems, their major milestones & accomplishments, and the companys outlook on the expanding psychedelic pharmaceutical sector.
  • Mycrodose Therapeutics started from a deep personal need to find better solutions for treating mental health.
  • Tickets: FREE Only Through This Link: https://microdose.buzz/discount/psycap/
    Mycrodose Therapeutics is a US-Based pharmaceutical company headquartered in San Diego, California specializing in the development of advanced drug delivery systems utilizing psychedelic compounds to treat mental health and cognitive degenerative diseases.

Phosphorus Launches GeneCompass™: The First Comprehensive, Affordable, Medical-Grade Preventative Genetic Test for Consumers

Retrieved on: 
Tuesday, July 13, 2021

NEW YORK, July 13, 2021 /PRNewswire/ --Phosphorus, a leading preventative genomics company, today announced the immediate availability of GeneCompass, the first holistic consumer genetic test built with medical-grade technology.

Key Points: 
  • NEW YORK, July 13, 2021 /PRNewswire/ --Phosphorus, a leading preventative genomics company, today announced the immediate availability of GeneCompass, the first holistic consumer genetic test built with medical-grade technology.
  • GeneCompass is the first holistic, medical-grade genetic test available as a proactive, preventative tool for consumers.
  • "It is time we finally made a medical-grade genetic test available as a proactive, preventative tool.
  • Additionally, Phosphorus provides the Elements software platform to enable any laboratory to easily deploy any of the Phosphorus genetic tests on-premise as a local solution.

Global Direct-to-Consumer (DTC) Genetic Testing Market Research Report 2021: Ancestry & Relationship to Account for $960 Million of the Total $2.3 Billion - Forecast to 2027 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 13, 2021

The "Direct-to-Consumer (DTC) Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Direct-to-Consumer (DTC) Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Ancestry & Relationship Testing, one of the segments analyzed in the report, is projected to grow at a 9.1% CAGR to reach US$960.8 Million by the end of the analysis period.
  • This segment currently accounts for a 21% share of the global Direct-to-Consumer (DTC) Genetic Testing market.
  • Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$116.7 Million by the year 2027.

Global Genetic Testing Market Research Report 2021: Market Witnesses Sluggish Growth during COVID-19, Set to Record Exponential Growth Post-COVID - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 13, 2021

The "Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Genetic Testing - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
  • Globally, prenatal testing market is expected to rise due to the increasing risk of chromosomal abnormalities associated with increasing maternal age.
  • One of the key growth drivers for new born and prenatal genetic testing is increased awareness about different chromosomal and genetic disorders.
  • Diagnostic genetic testing detects the presence of a certain genetic disease, like Huntington`s disease or cystic fibrosis through the detection of specific gene alteration.

US & EU Direct-to-consumer Genetic Testing Market Trends & Growth Opportunities 2021: Genomic Players will have to Transition to Disease-specific Tests, Advanced Kits, Technology & Services - ResearchAndMarkets.com

Retrieved on: 
Friday, July 9, 2021

The "US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "US & EU Direct-to-consumer Genetic Testing Market, Key Trends & Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • The genomic market is poised to grow at a much faster pace with real-time drug discovery, cutting-edge diagnosis, and technologically advanced treatment.
  • Genomic testing has proven to be a revolutionary tool in medicine, with applications including infectious disease diagnosis, cancer treatment selection, and non-invasive prenatal testing.
  • DTC-GT can be called directly by the consumer at home without any physician recommendation or through healthcare professionals, used for genealogy purposes.

Global Esoteric Testing Market (2021 to 2026) - Emerging Technologies in Esoteric Testing Presents Opportunities - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 6, 2021

The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.

Key Points: 
  • The global esoteric testing market is projected to reach USD 36.3 billion by 2026 from USD 21.0 billion in 2021, at a CAGR of 11.6% during the forecast period.
  • The esoteric testing market is segmented based on type, technology, end user and region.
  • Based on product, the esoteric testing market is segmented into infectious disease testing, endocrinology testing, oncology testing, genetic testing, toxicology testing, immunology testing, neurology testing, and other testing.
  • Infectious disease testing segment accounted the largest share of the esoteric testing market.

The Impact Factor and Immediacy Index Rise for AACC's Journal Clinical Chemistry, Reflecting the Journal's Groundbreaking COVID-19 Research

Retrieved on: 
Thursday, July 1, 2021

Throughout the course of the pandemic, clinical laboratory testing has played, and continues to play, a central role in managing the virus's spread.

Key Points: 
  • Throughout the course of the pandemic, clinical laboratory testing has played, and continues to play, a central role in managing the virus's spread.
  • Clinical Chemistry's impact factor and immediacy index are a testament to the journal's significant influence, as well as the relevance and timeliness of the research it publishes.
  • "We at AACC are excited to see Clinical Chemistry's impact factor and immediacy index climb," said AACC CEO Mark J.
  • This vital research is advancing areas of healthcare ranging from genetic testing and drug monitoring to pediatrics and appropriate test utilization.

Insights on the Genetic Testing Global Market to 2026 - Key Motivators, Restraints and Opportunities - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 1, 2021

The global genetic testing market is growing at a significant CAGR during the forecast period.

Key Points: 
  • The global genetic testing market is growing at a significant CAGR during the forecast period.
  • Genetic testing is a medical test that is used for the identification of mutations in genes or chromosomes.
  • The global genetic testing market is projected to considerably grow in the upcoming year due to the prevalence of genetic disorders, cancer, and chronic disease.
  • Moreover, the adoption of (DTC) direct-to-consumer genetic testing kits in countries such as the US, China, and Japan, is increasing rapidly.

United States In Vitro Diagnostics Market Report 2021-2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, July 1, 2021

The "United States In Vitro Diagnostics Market, Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Sales Analysis, Forecast" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "United States In Vitro Diagnostics Market, Impact of COVID-19, Industry Trends, Growth, Opportunity Company Overview, Sales Analysis, Forecast" report has been added to ResearchAndMarkets.com's offering.
  • In the United States, the growing prevalence of chronic and infectious diseases has spurred the development of the in-vitro diagnostics (IVD) market.
  • Besides, the United States In-Vitro Diagnostic market is broad and has various types of diagnostics instruments to perform different techniques.
  • In the United States, the In-vitro diagnostics market is currently in the South of the country, followed by the West being second.

BioSkryb Appoints Gary Harton, Ph.D., Chief Scientific Officer

Retrieved on: 
Wednesday, June 30, 2021

BioSkryb, Inc. , today announced the expansion of the companys leadership team with the appointment of Gary Harton, Ph.D., as Chief Scientific Officer.

Key Points: 
  • BioSkryb, Inc. , today announced the expansion of the companys leadership team with the appointment of Gary Harton, Ph.D., as Chief Scientific Officer.
  • Accurate whole genome amplification of single cells is key to understanding, diagnosing, and treating human diseases involving genomic heterogeneity, like cancer, said Jay West, Ph.D., CEO and cofounder of BioSkryb.
  • Prior to BioSkryb, Dr. Harton was the Portfolio Director, Preimplantation Genetic Testing responsible for Perkin Elmers new preimplantation genetic testing product line.
  • He has also been an author on numerous peer-reviewed scientific articles, abstracts, and book chapters and holds several part-time teaching positions in the US and abroad.